Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.7267
-0.0233-3.11%
Post-market: 0.72670.00000.00%19:44 EDT
Volume:3.33M
Turnover:2.47M
Market Cap:117.59M
PE:131.39
High:0.7801
Open:0.7492
Low:0.7002
Close:0.7500
Loading ...
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]